Table 11.
Identification of characteristic metabolites about chronic liver failure with nonbioartificial liver.
| Comparison of treatment methods | Detection of mass/charge ratio | The theory of mass/charge ratio | metabolite | VIP value |
|---|---|---|---|---|
| Plasma exchange and Bilirubin adsorption | 167.0 | 168.1 | uric acid | 2.03 |
| 407.3 | 408.6 | Cholic acid | 1.61 | |
| 112.1 | 113.1 | creatinine | 1.58 | |
| 391.3 | 392.6 | anthropodesoxycholic acid | 1.16 | |
| 303.2 | 304.5 | FFA 20_4 | 1.09 | |
| 167.0 | 515.7 | cholaic acid | 1.11 | |
| 286.3 | 284.5 | FFA 18_0-d3 | 1.08 | |
|
| ||||
| Plasma exchange and Hemofiltration | 167.0 | 168.1 | uric acid | 2.03 |
| 407.3 | 408.6 | cholalic acid | 1.61 | |
| 112.1 | 113.1 | creatinine | 1.58 | |
| 391.3 | 392.6 | anthropodesoxycholic acid | 1.16 | |
| 303.2 | 304.5 | FFA 20_4 | 1.09 | |
| 281.3 | 282.5 | FFA 18_1 | 1.40 | |
| 178.1 | 178.2 | hippuric acid | 1.33 | |
| 203.1 | 204.2 | L- tryptophan | 1.16 | |
|
| ||||
| Hemofiltration and Bilirubin adsorption | 281.3 | 282.5 | FFA 18_1 | 1.40 |
| 498.3 | 281.2 | phenylacetylglutamine | 1.28 | |
Note. VIP: variable importance in projection.